Five genes from chromosomal band 8p22 are significantly down‐regulated in ovarian carcinoma

Loss of heterozygosity on chromosomal band 8p22 is a common event in several epithelial tumors including ovarian carcinoma. So far, no clear evidence for a tumor suppressor gene (TSG) in this region has been found.

[1]  Jian Yu,et al.  Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis. , 2004, World Journal of Gastroenterology.

[2]  Peter A. Jones,et al.  Cancer-epigenetics comes of age , 1999, Nature Genetics.

[3]  Christoph Wanner,et al.  Identification of a new tumor suppressor gene located at chromosome 8p21.3–22 , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  A. Merdes,et al.  Assembly of centrosomal proteins and microtubule organization depends on PCM-1 , 2002, The Journal of cell biology.

[5]  G. Rustin,et al.  Molecular and biological factors in the pathogenesis of ovarian cancer. , 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  D. Karaoglu,et al.  Oligosaccharyltransferase isoforms that contain different catalytic STT3 subunits have distinct enzymatic properties. , 2003, Molecular cell.

[7]  T. Linke,et al.  Overexpression of Acid Ceramidase Protects from Tumor Necrosis Factor–Induced Cell Death , 2000, The Journal of experimental medicine.

[8]  W. Isaacs,et al.  Structure and methylation-associated silencing of a gene within a homozygously deleted region of human chromosome band 8p22. , 1996, Genomics.

[9]  R. Zeillinger,et al.  Determination of HER-2/neu amplification and expression in tumor tissue and cultured cells using a simple, phenol free method for nucleic acid isolation. , 1990, Oncogene.

[10]  P. Walsh,et al.  Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. , 1993, Cancer research.

[11]  R. Kreienberg,et al.  Morphological, immunohistochemical and biochemical characterization of 6 newly established human ovarian carcinoma cell lines , 1992, International journal of cancer.

[12]  R. Bast,et al.  Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer. , 1990, Cancer research.

[13]  L. Liotta,et al.  Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21. , 1996, Cancer research.

[14]  G. Chenevix-Trench,et al.  Sequence variants of DLC1 in colorectal ovarian tumours , 2000 .

[15]  E. Kohn,et al.  Allelic loss on chromosome arm 8p: analysis of sporadic epithelial ovarian tumors. , 1999, Gynecologic oncology.

[16]  Julian Peto,et al.  Identification of the breast cancer susceptibility gene BRCA2 , 1996, Nature.

[17]  S. Silverberg.  Histopathologic grading of ovarian carcinoma: a review and proposal. , 2000, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[18]  Mu-jun Zhao,et al.  HCRP1, a novel gene that is downregulated in hepatocellular carcinoma, encodes a growth-inhibitory protein. , 2003, Biochemical and biophysical research communications.

[19]  A. Orth,et al.  Large-scale analysis of the human and mouse transcriptomes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Y. Ishii,et al.  TMX, a human transmembrane oxidoreductase of the thioredoxin family: the possible role in disulfide-linked protein folding in the endoplasmic reticulum. , 2004, Archives of biochemistry and biophysics.

[21]  N. Copeland,et al.  The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer , 1993, Cell.

[22]  S. Tsukita,et al.  Non-membranous granular organelle consisting of PCM-1: subcellular distribution and cell-cycle-dependent assembly/disassembly , 2003, Journal of Cell Science.

[23]  T. Momoi.  Caspases involved in ER stress-mediated cell death , 2004, Journal of Chemical Neuroanatomy.

[24]  G. Chenevix-Trench,et al.  Sequence variants of DLC1 in colorectal and ovarian tumours , 2000, Human mutation.

[25]  Y. Bignon,et al.  Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer (review). , 2000, International journal of oncology.

[26]  D. Birnbaum,et al.  High frequency of allelic imbalance at regions of chromosome arm 8p in ovarian carcinoma. , 2001, Cancer genetics and cytogenetics.

[27]  Anne-Marie Alleaume,et al.  Trans-inactivation of Receptor Tyrosine Kinases by Novel Angiotensin II AT2 Receptor-interacting Protein, ATIP* , 2004, Journal of Biological Chemistry.

[28]  L. Aaltonen,et al.  Comparison of Serous and Mucinous Ovarian Carcinomas: Distinct Pattern of Allelic Loss at Distal 8p and Expression of Transcription Factor GATA-4 , 2001, Laboratory Investigation.

[29]  D. Lockhart,et al.  Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[30]  K. Rosendal,et al.  The growth-regulatory protein HCRP1/hVps37A is a subunit of mammalian ESCRT-I and mediates receptor down-regulation. , 2004, Molecular biology of the cell.

[31]  D. Ward,et al.  Mutation in the DNA mismatch repair gene homologue hMLH 1 is associated with hereditary non-polyposis colon cancer , 1994, Nature.

[32]  G. Chenevix-Trench,et al.  Chromosome 8 genetic analysis and phenotypic characterization of 21 ovarian cancer cell lines. , 2002, Cancer genetics and cytogenetics.

[33]  Steven E. Bayer,et al.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.

[34]  G. Chenevix-Trench,et al.  Frequent loss of heterozygosity and three critical regions on the short arm of chromosome 8 in ovarian adenocarcinomas , 1998, Oncogene.